Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Associated Banc-Corp F Pref | ASB-F | 24. dec 2024 | 20.45 | -0.39 |
Associated Bancorp | ASB | 24. dec 2024 | 24.37 | +0.45 |
Associated Capital Group | AC | 24. dec 2024 | 35.36 | -1.26 |
Assurant | AIZ | 24. dec 2024 | 215.43 | +1.91 |
Assured Guaranty | AGO | 24. dec 2024 | 88.93 | +1.05 |
AST SpaceMobile A | ASTS | 24. dec 2024 | 23.49 | +1.03 |
Astec Industries | ASTE | 24. dec 2024 | 33.15 | +0.61 |
Astera Labs | ALAB | 24. dec 2024 | 141.60 | +4.45 |
Astrana Health | ASTH | 24. dec 2024 | 33.48 | +0.03 |
AstraZeneca ADR | AZN | 24. dec 2024 | 66.30 | -0.50 |
Astria Therapeutics | ATXS | 24. dec 2024 | 9.54 | +0.21 |
Astronics | ATRO | 24. dec 2024 | 16.11 | +2.22 |
AstroNova | ALOT | 24. dec 2024 | 13.50 | +3.85 |
Astrotech | ASTC | 24. dec 2024 | 6.85 | +1.48 |
Asure Software | ASUR | 24. dec 2024 | 9.14 | +0.44 |
AT&T | T | 24. dec 2024 | 22.95 | +0.48 |
AT&T A Pref | T-A | 24. dec 2024 | 20.52 | -0.29 |
AT&T C Pref | T-C | 24. dec 2024 | 19.48 | -0.08 |
ATA Creativity Global ADR | AACG | 24. dec 2024 | 0.79 | -2.48 |
Atai Life Sciences BV | ATAI | 24. dec 2024 | 1.23 | +2.50 |
Atara Biotherapeutics | ATRA | 24. dec 2024 | 13.33 | +9.26 |
Atea Pharmaceuticals | AVIR | 24. dec 2024 | 3.25 | +0.31 |
Aterian | ATER | 24. dec 2024 | 2.32 | +5.69 |
Athena Technology Acquisition II | ATEK | 24. dec 2024 | 1.00 | 0.00 |
Athene A Pref | ATH-A | 24. dec 2024 | 23.89 | -1.36 |
Athene B Pref | ATH-B | 24. dec 2024 | 20.15 | -0.89 |
Athene C Pref | ATH-C | 24. dec 2024 | 25.05 | +0.12 |
Athene D Pref | ATH-D | 24. dec 2024 | 17.29 | -1.48 |
Athene Holding | ATH-E | 24. dec 2024 | 26.32 | -0.64 |
Athira Pharma | ATHA | 24. dec 2024 | 0.54 | +5.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.